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A B S T R A C T   
Key aims of the WHO Strategy to halve snakebite morbidity and mortality include health system strengthening 
and training of health workers. This requires knowledge of local health system needs and capacity, health worker 
training needs, and factors influencing health worker decision-making in snakebite management. This study 
explored health worker experiences and perceptions of snakebite management, both individually and in the 
context of their local health system. 
We used a qualitative study design with semi-structured interviews (n = 14) and focus group discussions (n =
4). We employed a combination of sampling strategies aiming to achieve maximum variation among key in-
formants within resource limitations. We recruited health workers (n = 33) of varying roles from purposively 
selected tier 2, 3 and 4 health facilities (n = 12) and the community (tier 1) in four sub-counties in Kitui County, 
Kenya. We conducted inductive thematic analysis of all transcripts. 
The results identified that health workers recognised snake envenoming as a time-critical emergency in which 
delay in care seeking, sometimes exacerbated by health system referral delays, was a major barrier to effective 
management of patients. Clinicians strongly voiced a need for training in snakebite management, diagnosis and 
antivenom administration. Unexpressed needs for training were demonstrated in traditional remedy ineffec-
tiveness, syndromic management, and critical appraisal of treatment effectiveness. Under-resourcing in anti-
venom, other medication, equipment, infrastructure and staffing also challenged management. Fear of snakebite 
and fear of antivenom, both linked to past experiences, influenced clinical decision-making. 
Our findings clearly indicate a need in Kitui County for training programmes that equip health workers for 
clinical decision-making in snakebite management. We further identify community intervention needs to facil-
itate prompt presentation to healthcare, including practical affordable transport solutions, and systematic health 
system resourcing needs. In addition, we recommend supportive supervision and further research in response to 
the emotional stress resulting from managing difficult cases in under-resourced settings.   
1. Introduction 
Snake envenoming is a preventable and treatable medical emergency 
(World Health Organization, 2019). Yet there are an estimated 1.8–2.7 
million cases of snake envenoming every year, resulting in 81–138,000 
deaths and 400,000 permanent disabilities (Kasturiratne et al., 2008; 
Chippaux, 1998; Peden et al., 2008). The majority of snakebite victims 
are impoverished and reside in rural, remote communities with poor 
access to rapid, effective health care (Harrison et al., 2009, 2019). 
Clinical management of snake envenoming is challenging. Clinical fea-
tures range from mild to fatal, vary by snake species and toxin class, and 
include local tissue damage and systemic features such as neurotoxicity 
or coagulopathy (World Health Organization, 2019). In addition, anti-
venom, the treatment of choice for systemic effects, poses high risks of 
acute adverse effects, including potentially life-threatening anaphylactic 
reactions (Gutiérrez et al., 2017). The rural, remote, tropical poverty 
context of most snakebite occurrences compounds the clinical chal-
lenges of improving treatment outcomes (Gutiérrez et al., 2017). 
The World Health Organization (WHO) strategy to halve snakebite 
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mortality and morbidity by 2030 recognises that strengthening health 
systems is a crucial component in delivering improved patient outcomes, 
making evidence on the capacity and needs of local health systems a key 
research need (World Health Organization, 2019). Health workers, as 
the core of the health system, the interface between patient and 
healthcare, and the route of healthcare delivery (Anand and 
Bärnighausen, 2012), are ideally placed to provide insight on their local 
health system. Health worker engagement is also a first step toward 
ownership and development of locally identified solutions, essential 
principles in delivering effective and sustainable improvements to 
healthcare quality (WHO Service Delivery and Safety Department, 
2018). 
Health workers are the agents of evidence-based diagnosis and 
treatment, which the WHO Strategy aims to deliver through training and 
development of decision-making tools and guidelines (World Health 
Organization, 2019). However, research suggests that implementing 
evidence-based practice may be challenged by a range of other factors 
that influence a clinician’s decision-making process, particularly past 
experiences, emotions and professional interactions (Hajjaj et al., 2010; 
Smith et al., 2008). Evidence from high and upper-middle income set-
tings is that patient factors, including socioeconomic status, attitudes 
and adherence to treatment, may also influence health workers’ decision 
making (Hajjaj et al., 2010; Mckinlay et al., 1996; Bernheim et al., 
2008). There is no evidence on whether, or how, these or other factors 
influence health workers’ approach to snakebite management as exist-
ing research in sub-Saharan Africa has focussed on health worker 
knowledge of snakebite (Michael et al., 2018; Ooms et al., 2020; Taieb 
et al., 2018). 
This qualitative study aims to meet this evidence gap in the context 
of the local health system in Kitui County, Kenya. Kenya has 13 medi-
cally important species of venomous snake resulting in an estimated 
15,000 bites a year (Kenya Ministry of Health Neglected Tropical Dis-
eases Program, 2019). These include spitting cobras, puff adders and 
other vipers, boomslang, cobras and mambas, which cause a range of 
haemorrhagic, coagulopathic, neurotoxic and local tissue destructive 
effects in victims of envenoming. We aimed to explore the perspectives 
of health workers on managing this range of snakebite pathology; on 
barriers to and enablers of effective management, and on their past 
experiences of and personal approach to clinical management. 
2. Methods 
2.1. Study site 
Kitui County is in the east central region of Kenya, a terrain domi-
nated by arid and semi-arid regions receiving irregular and erratic 
rainfall. Its economy is dependent on agriculture. 2016 levels of absolute 
(47.5 %) and food (39.4 %) poverty were both higher than Kenyan na-
tional average (County Government of Kitui, 2018). Climate, agricul-
tural activities and poor housing all contribute to a high incidence of 
snakebite from a range of medically important snakes, including red 
spitting cobra (Naja pallida), puff adder (Bitis arietans) and black mamba 
(Dendroaspis polylepis) (Kihiko, 2013). 
The study took place in 2019 in four sub-counties in northern Kitui 
county (Table 1) that vary in rainfall and population density, which are 
respectively positively and inversely correlated with snakebite incidence 
(Rahman et al., 2010; Chaves et al., 2015; County Government of Kitui, 
2018). Rainfall is greater in the highlands, including areas of Mwingi 
North and Kitui East, than in the lowlands, including much of Mwingi 
West, Mwingi Central and the eastern part of Kitui East (County Gov-
ernment of Kitui, 2018; Kenya Ministry of Environment et al., 2015). We 
chose study areas with varying snakebite incidence because snakebite 
burden may be an influence on management challenges. The study was 
embedded within a larger project of the Kenya Snakebite Research and 
Intervention Centre (K-SRIC) for the African Snakebite Research Group 
(Centre for Snakebite Research and Interventions, 2021). 
2.2. Study design 
We chose a qualitative study design to allow in depth exploration of 
health worker perceptions and attitudes on snakebite management 
(Green and Thorogood, 2004). We used a qualitative description 
approach, seeking to provide a rich description of the experiences and 
perceptions of managing snakebite in Kitui County, allowing us to 
identify unknown factors that influence health worker management of 
snakebite, begin to understand their inter-relationships and inform in-
terventions (Bradshaw et al., 2017). We used focus group discussions 
(FGDs) to rapidly generate debates, allowing for emergence of themes 
and conflicting or deviant ideas (Morgan, 1998). We used individual 
semi-structured interviews (SSIs) to allow participants to freely explore 
more sensitive topics, including personal experiences, emotions, and 
beliefs (Gill et al., 2008). Triangulating both methods allowed us to 
explore shared and contrasting individual and collective views (Green 
and Thorogood, 2004). 
2.3. Sampling and recruitment 
2.3.1. Healthcare facilities 
The Kenyan public health system is loosely divided into four tiers 
(Kenya National Coordinating Agency for Population and Development 
et al., 2011), described in Table 2. Antivenom for snakebite treatment is 
typically available only in tier 4 (hospital) and some tier 3 (health 
centre) facilities. Admission for more than about 6 h’ observation is only 
available in tier 4 facilities. We included tier 2 (dispensary), 3 and 4 
health facilities because snakebite victims most commonly present to 
such facilities and the focus was on management within healthcare 
(Gutiérrez et al., 2017). We also included community health workers 
(tier 1) as their role gives them a unique understanding of care seeking 
for snakebite. 
We purposively selected government health facilities by maximum 
variation sampling (Marshall, 1996) across sub-county, health facility 
tier, travel distances and snakebite presentations (Table 3). This strategy 
aimed to ensure we included health workers from settings varying by 
patient population, facility resources, snakebite workload and experi-
ence, and ease of referral, allowing exploration of whether and how 
these factors influenced decision-making. 
Abbreviations 
CHW Community Health Worker 
FGD Focus Group Discussion 
K-SRIC Kenya Snakebite Research and Intervention Centre 
PHO Public Health Officer 
SSI Semi-Structured Interview 
WHO World Health Organization  
Table 1 
Characteristics of study sub-counties. All data is for 2018, from the County 
Government of Kitui (2018) and the Kenyan Ministry of Health (2018).  
Sub- 
county 
Population Population 
density (persons/ 
km2) 
Estimated number of snakebite 
presentations to public health 
facilities Jan–Dec 2018 
Mwingi 
North 
155 267 32 83 
Mwingi 
West 
115 117 106 135 
Mwingi 
Central 
156 641 38 196 
Kitui East 136 708 27 106  
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2.3.2. Semi-structured interviews (SSIs) 
We selected participants for SSIs from all smaller participating health 
facilities using opportunistic sampling at each site visit. Logistical issues 
prevented sampling by an alternative method. We supplemented this 
with key informant and deviant sampling (Marshall, 1996) from FGD 
participants, inviting those who demonstrated in-depth knowledge, 
numerous experiences or outlier ideas for an SSI to explore these in more 
depth. There were no repeat interviews other than a single instance of 
sampling from an FGD. 
2.3.3. Focus group discussions (FGDs) 
We conducted FGDs in larger facilities able to provide 4–6 eligible 
health workers for an FGD. In three facilities, we selected participants by 
key informant sampling of departments managing most snakebite cases 
(surgical, paediatric and emergency departments) and maximum vari-
ation sampling of professional groups within each department (nurses, 
doctors and clinical officers) (Marshall, 1996). This enabled us to 
include, compare and contrast perspectives of the full range of staff who 
manage most snakebite patients. However, nurses manage most snake-
bite patients (Gutiérrez et al., 2017) and it was possible that some might 
be discouraged to freely share their opinions by the presence of staff at a 
different position in the healthcare professional hierarchy. Therefore, in 
one facility, we selected FGD participants by homogeneous sampling of 
only nurses, creating an opportunity for their perspectives to be shared 
free of the workplace hierarchy and exploiting a natural group used to 
working together (Gutiérrez et al., 2017). 
2.3.4. Recruitment 
We routinely first approached the sub-county Public Health Officer 
(PHO)/Medical Superintendent, who provided a link to the manager or 
medical officer of each selected facility. After providing study infor-
mation, we asked this gatekeeper for permission to approach staff in 
their facility regarding the study. Because of the complexity of arranging 
an FGD with staff with clinical commitments, the relevant facility 
gatekeeper recommended a date, time and participants for each FGD. 
We gave every prospective participant at least 48 h to review a partic-
ipant information sheet in English and Swahili, which explained the 
study purpose and process, and an opportunity to discuss the study with, 
and be introduced to the researcher (KB) before taking written informed 
consent. No invited participant refused to participate, stating they were 
keen to share their views and experience. 
2.3.5. Participant characteristics 
33 health workers from the four sub-counties participated in the 
study across 14 SSIs and four FGDs (Table 4). Participant roles are shown 
in Table 5. Participant ages ranged from 20 to 74, with over half (19) 
aged between 25 and 39. There were 15 male and 18 female 
participants. 
2.4. Data collection 
We developed a topic guide for use in both SSIs and FGDs. The initial 
structure was informed by existing literature on factors influencing 
clinical decision making. Local researchers and PHOs advised on adap-
tations to increase its suitability for use in Kitui County. We made 
further refinements based on a pilot SSI and FGD in two different health 
facilities and experience throughout the study, either to follow-up 
participant responses or to refine questions for clarity. This process 
was recorded in a reflexive diary. Separate field notes were not kept. The 
Table 2 
Key services and health workers present at facility tiers 1–4 in the Kenyan 
government health system. Information taken from the Kenya Service Provision 
Assessment Survey 2010 (Kenya National Coordinating Agency for Population 
and Development et al., 2011) and KSRIC experience of snakebite management 
in the local health system. CO = Clinical Officer. AV = antivenom.  
Tier Facility Key Services Health workers 
(* = main 
decision-maker 
and prescriber) 
Typical role in 
snakebite 
management 
1 Community 
unit 
Community 
level care and 
health 
promotion 
Community 
health workers 
and volunteers; 
occasionally 
nurses 
Support 
presentation to 
facility. 
2 Dispensary Basic outpatient 
care 
Nurses and 
nurse-in- 
charge* 
Initial assessment 
and referral. Most 
do not stock AV. 
3 Health 
centre 
Outpatient care; 
Preventative 
services; Minor 
surgical services 
Nurses; CO*; 
occasionally 
doctors* 
Some stock AV. 
May treat and/or 
refer. Maximum 
observation period 
circa 6 h. 
4 District 
hospital 
Surgical, 
medical and 
paediatric 
services; 24 h 
services 
Nurses; CO*; 
Doctors* 
Stock AV. Full 
treatment and 
admissions. All 
snakebite patients 
usually admitted 
for 24 h.  
Table 3 
Description of included facility characteristics. All distances and times were estimated using Google maps. Estimated snakebite presentations to the facility in 2018 
from Demographic Health Information Systems Data provided by the Kenyan Ministry of Health (2018). Numbers <10 suppressed. Facility names are excluded to 
maintain participant confidentiality in smaller facilities.  
Sub-county Facility 
tier 
Distance from main road 
(km) 
Distance to referral hospital 
(km) 
Time to referral hospital 
(mins) 
Estimated number of snakebite presentations in 
2018 
Mwingi 
Central 
3 0 33 30 17 
3 30 64 90 11 
4 0 – – 63 
Mwingi West 2 5 35 45 <10 
2 20 35 40 70 
2 0 10 15 <10 
4 0 – – <10 
Mwingi North 3 5 55 60 <10 
3 30 90 130 21 
4 0 – – 11 
Kitui East 2 10 15 40 <10 
3 0 24 40 <10  
Table 4 
Data collection methods used in each sub-county.  
Sub-county Number of interviews Number of FGDs 
Mwingi North 3 1 
Mwingi Central 3 1 
Mwingi West 3 2 
Kitui East 5 0 
Total 14 4  
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final topic guide can be found in Supplementary File 1. All researchers 
received training on qualitative research methods. 
All data was collected in 2019 by KB, a male British medical student, 
as part of an MSc degree during which he received training in qualitative 
research methods. He was introduced to all study facilities by a member 
of the K-SRIC team, whose work meant they had previously developed 
relationships with communities and health facilities in Kitui County. We 
felt use of an outsider interviewee would support health workers feeling 
they could freely share positives and negatives of their own practice 
independent of their supervisors or local authorities, and that the link to 
a local team provided confidence the results would be used locally. The 
shared medical background between interviewer and interviewee 
enabled participants to use their normal work language. While, KB was 
aware of the differences in experience and background between himself 
and participants, and of his biomedical bias, he was able to use this 
awareness and an interest in broader healthcare to ask non-judgemental 
questions. 
We conducted SSIs and FGDs in each study facility, either in a quiet 
side room (SSIs) or private meeting room (FGD). SSIs were 30–60 min in 
duration and FGDs circa 60 min. All were audio recorded for later 
transcription. We collected most data in English, an official language in 
Kenya and in which all health workers in Kitui were conversant. How-
ever, two participants were less confident in English and chose to 
conduct their SSI using an English-Kamba interpreter. We trained the 
interpreter in interpreting for qualitative interviewing (Murray and 
Wynne, 2001) and they were familiarised with the topic guide. We used 
a three-way interpreting technique to allow the researcher to probe and 
clarify the interpretation, and to ask questions about emotional re-
sponses, such as laughter. A bilingual member of the K-SRIC team 
back-translated one SSI to confirm the validity of the interpretation. 
Data collection was deemed complete when target theoretical sample 
size was reached and themes emerged. Study limitations and timescales 
did not allow continued data collection for full data saturation. 
2.5. Data analysis 
We transcribed and analysed all SSIs and FGDs in English. The pilot 
FGD and SSI were not included in analysis. We carried out inductive 
thematic analysis supported by ‘Nvivo 11’ (NVivo, 2015). Two re-
searchers independently coded three transcripts before discussing and 
agreeing a coding scheme (Green and Thorogood, 2004). One researcher 
coded all remaining transcripts, with further iterative adaptations to the 
coding scheme discussed and agreed by two researchers. The coding 
scheme is provided in supplementary file 2. We explored relationships 
between codes, similarities and conflicts within and between individual 
participants and checked for patterns across the whole dataset and by 
participant and facility characteristics to identify and construct themes. 
We carried out refutational searches, checking for any disagreement 
with proposed patterns and themes. We agreed on three key themes, two 
of which had sub-themes. Project timescales and study geography did 
not allow for participant checking of transcripts or findings. 
2.6. Ethical considerations 
The Liverpool School of Tropical Medicine MSc Review Panel 
(Application 1924) and the Kenyatta National Hospital - University of 
Nairobi Ethics and Research Committee (Amendment to existing study 
P347/05/2019) approved the study. 
3. Results 
3.1. Delays: a major barrier to effectively managing this time-critical 
emergency 
All participants identified delays as a barrier to effective snakebite 
management and/or described snake envenoming as a time-critical 
emergency. Some, representing every facility tier, described specific 
cases in which they felt delays had been a direct cause of adverse out-
comes, including digit or limb amputation or death. 
“The management of a snakebite, I am slowly discovering that time is a 
factor that is very much essential. The time taken after a bite to seek 
medical attention” (SSI, tier 3 facility) 
“I had an experience here last year … It was a child who was bought here 
having been bitten by the red snake … The child was referred because at 
that time we had no anti-snake venom … Instead, the parents did not take 
the child immediately … They went home, they started looking for other 
means of survival and in the course of that the child died the same day … 
Snakebite kills. Especially when there is a delay in terms of management.” 
(SSI, tier 3 facility) 
3.1.1. Delays in care seeking a priority, requiring community education and 
preparedness 
All participants discussed delay between bite incidence and reaching 
the health facility as a primary cause of delay in management. Partici-
pants attributed, either in general or when discussing specific cases, 
these delays to a range of causes, which could be divided into stages of 
the process from snakebite to presentation, described in Table 6. 
P1: "We’ve amputated a 6 year old girl, an above knee amputation due to 
a venomous snakebite. But she had stayed for more than a week at home 
so the limb was already gangrenous … Most people, there is something 
that they usually apply, some black stone. Then they go to some healer so 
before they come here they have already taken quite some time at home 
because of those beliefs and whatever they do at home. That is the major 
contributing factor." 
P3: "… There is that culture but then there is also an aspect of poverty. 
When a patient is bitten by a snake and they don’t have transport to come 
to the hospital, so that poverty issue is another contributing factor. And 
also poor knowledge of what can happen after a snakebite. But I think 
most of it is that traditional culture, poor knowledge and even poverty 
level. When somebody doesn’t have anything to bring themselves to the 
hospital." (FGD, tier 4 facility) 
Most participants perceived a lack of community knowledge of 
snakebite management, trust in traditional remedies, poverty, cost of 
transport and distance from the facility as key drivers of delay. Some 
described these factors as inter-related, linking the indirect cost of 
accessing healthcare to choosing traditional remedies. Many also cited 
the underlying social determinants of snakebite incidence and delay in 
accessing care (Table 6). 
Participants, with the exception of three SSI respondents, all linked 
delay to accessing healthcare with a need for community engagement 
and education and/or preparedness in terms of transport to a health 
facility. Participants described needing to educate communities on 
preventing snakebite, first aid and immediate attendance at a health 
facility, both proactively in the community and reactively with in-
dividuals who present with snakebite. A few participants mentioned 
positive progress in community attitudes to care seeking and traditional 
remedies or the positive impact of the snakebite motorbike ambulance 
currently being researched in some areas. A few also cited the positive 
Table 5 
Participant occupations by data collection method.   
Community 
health 
volunteer 
Nurse Nurse in 
charge 
Clinical 
Officer 
Doctor Public 
health 
officer 
FGDs 0 14 1 3 1 0 
SSIs 2 3 2 6 0 1 
Total 2 17 3 9 1 1  
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impact of Kitui Health Cover in making treatment free of charge, while 
noting its impact was limited by some eligible people not having taken 
up cover and because it did not remove the cost of transport to a health 
facility. 
3.1.2. Further delays to receipt of treatment after accessing care result from 
inconsistent ability of health facilities to manage snakebite and limited 
referral infrastructure 
Most participants described the time between deciding to refer a 
patient to another facility with the expertise and resources to manage 
snakebite and their arrival at that facility as an important cause of delay. 
Issues cited were the distance between facilities, reliance on deployment 
of an ambulance at another facility increasing travel time, limited 
ambulance numbers resulting in frequent unavailability and health 
system prioritisation of maternity cases over all other cases. Some par-
ticipants also described difficulties finding affordable alternative trans-
port if there was no ambulance available. A few said they had personally 
offered loans to patients to fund their transport. Participants stated that 
“the main reason we refer people is for antivenom” (SSI, tier 3 facility) and 
five advocated for antivenom being available in all facilities to remove 
these delays. 
“We couldn’t give antivenom so we had to refer. At that time, we only had 
one ambulance and it was already out taking another patient so we had to 
wait until that ambulance came back before the patient was taken. She 
reached but later she died because of the delay of treatment” (SSI, tier 4 
facility) 
While one participant did describe the ambulance service as reliable, 
they had never needed to use it for a snakebite case. 
A few participants linked gaps in knowledge or resources to delay 
because of the time taken to consult colleagues, either in facility or at 
another facility, or research guidance. A few described delays due to 
needing to borrow antivenom from another facility. 
3.2. Both expressed and normative needs for training and system 
resources identified 
3.2.1. Clinical training needs strongly expressed by patient-facing 
professionals 
Every participating clinician, by which we mean a patient-facing 
health professional delivering care in tier 2,3 and 4 facilities, 
expressed a desire for training in snakebite management. Most of these 
participants said they were not confident managing snakebite. 
“I think … at long last people will come to the facility, so one of the biggest 
challenges we have now is the knowledge gap in the healthcare workers.” 
(SSI, tier 3 facility) 
“I had no idea of the management … I have that knowledge gap so 
training is needed, or updates on snakebite management.” (SSI, tier 2 
facility) 
A few clinicians expressed some confidence, all but two of whom had 
received some training. In one FGD, statements of confidence were led 
by the facility lead saying they were confident in their staff, who had 
been trained. Five other participants expressed limited confidence, but 
stated they were not confident giving antivenom. Participants from five 
facilities reported having received some form of post-qualification 
training. Three of these described limitations; one could not attend the 
whole training, one described it as “very shallow” (FGD, tier 2 facility) 
and one said it was “sensitisation … some years back, I think 2003” (FGD, 
tier 4 facility). 
Participant descriptions of training needs are illustrated in Table 7. 
The most frequent needs were a general request for training in clinical 
management and specific requests in accurately identifying venomous 
from non-venomous bites and using antivenom. Antivenom-related re-
quests were the only training requests patterned by either facility or 
health worker characteristics. Six of the nine individuals or groups 
wanting antivenom training worked in facilities which currently or had 
recently stocked antivenom. The other three all viewed training as a 
required component of bringing antivenom to more facilities as a solu-
tion to referral delays. One of these described their facility having once 
had antivenom in stock but being unable to give it to patients with 
snakebite because no-one was trained. Antivenom training requests 
included storage, when to (not) give, how to give, and management of 
adverse reactions. 
A few participants made recommendations on the nature of or system 
for training. A few requested posters and flow charts for display in fa-
cilities. A few advocated for in-facility or nearby rather than distant 
training, and repeated sessions to ensure staff transferred into a snake-
bite region were trained. One highlighted the need for senior 
Table 6 
Participant descriptions of perceived drivers of delay and contributing context 
on the journey of a snakebite victim from bite to a health facility.  
Key points on the snakebite 
victim’s route to a health 
facility 
Perceived driver of delay Underlying social 
determinants 
Recognising a snakebite Low snakebite knowledge 
in the community 
Health literacy and 
education 
Night-time bites (sleep 
and darkness affecting 
recognition) 
Poor quality housing 
Sight of biting animal 
limited by bush/foliage 
Rural environment 
and activities 
Unsupervised children 
unable to give history 
Understanding the need for 
healthcare after a 
snakebite and where to 
access it 
Low snakebite knowledge 
in the community 
Health literacy, 
including awareness 
of health care 
Uncertainty over which 
facilities can manage 
snakebite or stock 
antivenom 
Belief/trust in traditional 
remedies 
Cultural and/or 
religious norms 
Superstition or spiritual 
beliefs that curses are a 
cause of snakebites 
Religious beliefs that 
prohibit accessing 
healthcare (Kavonokya 
sect) 
Having or obtaining the 
means to access healthcare 
(communication and/or 
transport) 
Not owning a mobile 
phone 
Communication 
infrastructure 
Remote rural location 
Transport 
infrastructure 
Poverty 
Being in an area with no 
mobile network coverage 
(patient or CHV) 
Not owning a vehicle 
Not having any fuel for 
the vehicle 
Lack of funds for fuel or 
hiring transport 
Time needed to obtain 
informal community 
support to identify funds 
or transport 
Travel to health facility Distance to health facility Remote rural location 
Health system 
delivery model 
Road infrastructure 
Road quality limiting 
transport options to 
slower choices (walk/ 
motorbike) 
Flooding and road 
damage after rains  
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commitment to snakebite management training to ensure all staff, 
including those in single-staffed facilities, received it. 
3.2.2. Traditional beliefs and remedies illustrate normative training needs 
Participants showed varied attitudes to traditional remedies. Most 
participants advised against tourniquets and cutting, describing harm 
due to ischaemia and haemorrhage or infection respectively. Three 
participants said tourniquets were effective. The black stone was a 
source of debate. Five participants confidently stated that the black 
stone did not work, while four felt it did work, one of whom said it 
worked specifically for a “dry bite”. Ten participants from all facility 
tiers expressed uncertainty over whether it did work, some of whom felt 
it gave psychological benefit and a few of whom identified it as a 
research need. Participants did not discuss whether application of a 
black stone was preceded by cutting. Most of those who said traditional 
remedies or tourniquet were effective were from the community or tier 2 
facilities, but not all. 
“The stone we don’t remove. We keep it there until it falls down so you 
find the client feels like I’m okay now, I have been cured, because it is their 
belief.” (SSI, tier 2 facility) 
Many described traditional beliefs as a cause of delay in care seeking, 
but some, including both community health volunteers, found it difficult 
to advise against them, mostly the black stone, in the context of the 
remote location of most snakebites, patient report of benefit, and the 
absence of alternatives. A few described having themselves bought a 
black stone. 
“I will not discourage them using that [black stone], whatever means they 
have. I will not discourage them because I don’t know if it works.” (FGD, 
tier 4 facility) 
3.2.3. Gaps in health infrastructure and resourcing are a barrier to 
snakebite management 
3.2.3.1. Antivenom. Participants from six facilities (three tier 4, two tier 
3, one tier 2) reported that they currently stock antivenom, but all six 
facilities said stock-outs were an issue and three facilities described 
borrowing antivenom from other facilities. 
“Now the two [antivenom] vials that we have [been] given, one is expired 
so we don’t have them. So now it’s difficult to manage a snakebite.” 
(FGD, tier 2 facility) 
Of the remaining six facilities who didn’t stock antivenom, one 
previously had but couldn’t at the time of the interview because of a 
broken fridge, one reported having once received antivenom that no-one 
knew how to administer, and one said it was ordered but never received. 
3.2.3.2. Other medication, equipment and infrastructure. Participants 
from all three tier 4 facilities stated they had sufficient other resources 
for snakebite management except for one participant saying they lacked 
specialist equipment for limb elevation. However, participants from 
seven of the nine tier 2 or 3 facilities described lack of in-facility re-
sources as barriers to effective emergency management. While some of 
these referred to gaps in equipment or medicine stock in general, the 
following specific resource needs were mentioned in at least one tier 2 or 
3 facility; electricity and lighting (3 facilities), adequate bed capacity for 
observation (2 facilities), equipment for monitoring vital signs (2 facil-
ities), oxygen supply (1 facility), analgesia (1 facility), anaphylaxis 
medications (1 facility) and laboratory investigations (1 facility). 
“Sometimes we have failure of our equipment, like you can’t check the 
vital signs … because of failure of the equipment we have. So, in short, 
you’re just using your eyes … If the patient is in pain we can give pain 
killers and most of the time the villagers also have some slight idea of how 
to manage it, some of them have the black stone, some don’t have, some 
tie … But sometimes we also lack the pain killers.” (SSI, tier 2 facility) 
3.2.3.3. Human resources. Participants from eight of twelve health fa-
cilities and the community described under-staffing as an issue. This was 
mostly linked to challenges managing multiple patients, with one saying 
it added to fear of antivenom complications. A few linked understaffing, 
mostly lone working, to low confidence in management and being un-
able to consult colleagues. Some described informal consultation of 
friends and colleagues as a route to addressing this isolation. 
3.3. Tension between fear of snakebite and fear of antivenom, both linked 
to past experiences 
Fear was the dominant emotion participants used to describe snakes 
and snakebite and connected this to the severity of the potential out-
comes, from life-changing wounds or amputations to death. Some par-
ticipants described greater worry over children presenting with 
snakebites, and in a few cases, pregnant women. 
However, there was a difference in health worker fears and tension 
between facilities that did or did not routinely stock antivenom. Par-
ticipants in facilities without antivenom described fears, tension and 
strain being exaggerated by feeling unable to help patients. 
“I just felt pity because … I have nothing I can do with this patient so I had 
to refer immediately and felt sorry because when you have a patient and 
you can’t manage you feel like you have done nothing. And they were not 
satisfied because no first aid, nothing. They were like, you don’t have the 
antivenom?” (SSI, tier 2 facility) 
Those with experience of giving antivenom discussed side-effects. 
Some felt this was a reason for additional caution and/or senior super-
vision, but were still positive about antivenom. These participants had 
all either not experienced antivenom reactions or had successfully 
managed reactions. Many described experiences in which they directly 
linked administration of antivenom to a good patient outcome or delay 
in receipt of antivenom to an adverse patient outcome. Two participants 
described deaths of patients not receiving antivenom after the clinical 
team had disagreed on whether to give antivenom. 
“So, what I think my self is, there are very few patients who react on it. So, 
we cannot fear giving the antivenom because it is the only saviour of that 
patient. So, if we have the phobia of giving the venom then we are not 
helping that patient in anyway. So maybe out of 20 only one will react. 
Unless when a patient comes and he or she is very late in the hospital. You 
don’t understand whether it is the venom which is in the blood or what. 
Sometimes you are confused, is it the venom, is it the antivenom. So ac-
cording to me that reaction is not so high. There are very few. So, for me I 
think we need the antivenom … It comes to that extent you don’t know 
Table 7 
Areas of training requested by patient-facing health professionals. Patient-facing 
health professionals in this study (n = 30) were nurses, nurses in charge, doctors 
and clinical officers across 11 SSIs and 4 FGDs.  
Requested area for training Number of FGDs/SSIs in which 
identified 
Tier 2 
(n =
6) 
Tier 3 
(n =
5) 
Tier 4 
(n =
4) 
Total 
(n =
15) 
Case management 4 3 2 9 
Accurate diagnosis of venomous 
snakebites 
4 2 2 8 
Antivenom 2 2 4 8 
… Of which specifically mentioned 
adverse reactions 
1 0 4 5 
Counselling patients, advising community 1 1 1 3  
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what else you can do for the child. Although we have a minor fear you just 
give, you cannot just deny. There is a little fear of what will happen but 
you still give.” (FGD, tier 4 facility) 
However, some experienced fear of antivenom, mostly because of 
adverse reactions. The three participants who expressed greatest fear all 
described experiences of patient deaths from (sometimes suspected) 
antivenom reactions. Three participants said they had not given avail-
able antivenom because of fear, while a few others described referrals 
because other facilities were not willing to give antivenom. 
P4: "You fear these days. You don’t know the severity to give the anti-
venom and when not to give the venom so that’s why we say it’s better to 
give the other resuscitative drugs." 
P3: "Eh, it’s better without antivenom. " 
P4: "Some experiences make us just fear." (FGD, tier 4 facility) 
4. Discussion 
Health workers from a range of tier 2, 3 and 4 health facilities in Kitui 
County all described delay in presentation to healthcare, which could be 
exacerbated by further delays within the health system, as a major 
barrier to effective management of patients with snake envenoming. In 
terms of personal approach to management, a picture emerged of cli-
nicians feeling the tension of difficult choices when trying to minimise 
harm to the patient. The life and limb-threatening potential of snake 
envenoming was in tension with recognised risks of treatment; referral 
to another facility risked delay and out of pocket expenditure, while 
administering antivenom risked potentially severe adverse reactions. 
Past experiences were major influences on this risk assessment and 
feelings of worry. Most clinicians described facing this high- 
consequence decision-making in a context of little training in snake-
bite management and facility under-resourcing. 
4.1. Community engagement, traditional remedies and care seeking 
behaviour 
Both the WHO Snakebite Strategy (World Health Organization, 
2019) and our participants identify a need for community engagement 
and education on snakebite prevention, first aid and care seeking. The 
enduring community belief in and use of traditional snakebite-remedies 
seen in our study was similar to that reported in surveys in other set-
tings, including Nigeria, India, Myanmar and Sri Lanka (Iliyasu et al., 
2015; Mahmood et al., 2019; Samuel et al., 2020; Ediriweera et al., 
2017). However, our qualitative methods enabled identification of a 
relationship perceived by health workers between use of traditional 
remedies and cost of, or difficulty reaching healthcare. This relationship 
was also described in a qualitative study on snakebite in Myanmar 
(Schioldann et al., 2018). While evidence from the community itself is 
needed, our findings highlight that community education on care 
seeking for snakebite will need to be accompanied by practical solutions 
to enable access to healthcare, such as free or reduced cost emergency 
transport, for maximum effectiveness. 
Our study adds to the existing evidence that some health workers in 
sub-Saharan Africa believe in the effectiveness of traditional remedies 
(Ooms et al., 2020; Taieb et al., 2018; Michael et al., 2018). Such 
remedies are advised against in International and Kenyan guidelines for 
snakebite management (World Health Organization Regional Office for 
Africa, 2010; Kenya Ministry of Health Neglected Tropical Diseases 
Program, 2019). Our qualitative findings provide new understanding 
that health workers are more confident advising patients against tradi-
tional remedies where they clearly understand the harms of the rem-
edies, and less confident where they feel their own knowledge is limited 
or they have no good alternatives to offer. This latter attitude was 
typified in the black stone, which was only identified as harmful if it 
contributed to delayed presentation at a health facility. Participants did 
not explicitly associate the black stone with cutting, which accords with 
a 2018 Kenyan leaflet publicising black stone that did not advocate 
cutting before its application (Rural Extension with Africa’s Poor 
(REAP), 2018). Local practices in applying black stone should be 
researched, but these findings raise the possibility of a 
harm-minimisation approach in which traditional healers are engaged 
to facilitate prompt transfer to a health facility, but may choose to apply 
a black stone without cutting. A similar strategy to integrate traditional 
healers into community education, first aid and transport to health fa-
cilities was proposed by researchers in Myanmar after noting persistent 
beliefs in traditional remedies for snakebite and under-use of healthcare 
(Schioldann et al., 2018). Further research and engagement with the 
community and traditional healers is needed to explore this. On a wider 
perspective, our findings indicate an urgent need for 
close-to-community treatment to address both delay to treatment and 
use of traditional remedies. Research to develop new toxin-neutralising 
small molecule-based snakebite treatments holds considerable promise 
because their safety, non-cold chain dependency, oral delivery and 
affordability characteristics suggests they could be dispensed at 
community-level facilities, instead of in hospital – a paradigm shift in 
snakebite management (Albulescu et al., 2020). 
4.2. Health worker training needs and system resourcing 
Our findings highlight that satisfactory care is needed to reinforce 
presentation to a health facility, and that significant training and 
resourcing is required to ensure consistent quality care. Participating 
clinicians’ demand for patient-management focused clinical training 
and aids such as management flow charts is reflected in the objectives of 
the WHO Snakebite Strategy, launched the same year as this study 
(World Health Organization, 2019). Our findings provide the first pub-
lished descriptions by health workers of their needs in clinical snakebite 
training. General requests for “case management” training suggest low 
baseline knowledge, while specific requests focused on diagnosis and 
antivenom. The link many made between distinguishing venomous from 
non-venomous snakes and antivenom administration suggests that, in 
common with health workers in Nigeria (Michael et al., 2018), some 
health workers think antivenom treatment is indicated for all bites from 
venomous snakes. This indicates poor participant knowledge of syn-
dromic management, advised in International and Kenyan snakebite 
management guidelines (Kenya Ministry of Health Neglected Tropical 
Diseases Program, 2019; World Health Organization Regional Office for 
Africa, 2010). The presence of unexpressed training needs (syndromic 
management, traditional remedy ineffectiveness and critical appraisal of 
association, causation and evidence of effectiveness) suggests that 
training priorities identified by health workers will need to be combined 
with normative assessments of essential training in snakebite 
management. 
We identified that health system resourcing needs ranged from the 
basic (eg. lighting) to the more complex (eg. antivenom supply). Our 
findings of stock-outs being a challenge in snakebite management 
indicate that the stock-outs reported in a 2009 Kenyan government 
survey remain an ongoing issue (Ministry of Medical Services and 
Ministry of Public Health and Sanitation, 2009). This reflects a 
continent-wide shortfall in antivenom, with an estimated less than 5 % 
of a required 1.5–2 million antivenom doses being supplied annually 
(Stock et al., 2007; Brown, 2012). While addressing these stock-outs 
requires action at a national and international tier from stakeholders 
in health, pharmaceuticals, government and regulatory agencies (World 
Health Organization, 2019), our findings indicate these need to be 
combined with local interventions such as ensuring fridges are func-
tional and deliveries are made to facilities with trained staff confident to 
administer antivenom, thereby ensuring available stocks are not wasted. 
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4.3. Health worker emotions associated with managing snakebite 
To our knowledge, this is the first confirmation of anecdotal reports 
of health workers deciding against administering available, indicated 
antivenom because of fear of antivenom-induced adverse reactions 
(Warrell, 2010). Little is known about the exact frequency of adverse 
reactions to antivenom in Kenya specifically, but national guidelines 
recognise their potential for serious adverse effects and recommend 
consideration of pre-treatment with subcutaneous adrenaline to reduce 
their incidence (Kenya Ministry of Health Neglected Tropical Diseases 
Program, 2019). Although we cannot comment on incidence, we iden-
tified reports of past, negative experiences of managing 
antivenom-induced adverse reactions having a major bearing on health 
worker lack of confidence in using antivenom to manage a patient. As 
management of adverse effects of antivenom was also identified by 
participants as a training need, it is difficult to know how much of this 
fear can be addressed by training in managing adverse reactions and 
whether, and if so to what extent, further support in processing past 
experiences would be indicated. It is clear, however, that health workers 
find the training and resourcing gaps emotionally challenging in their 
impact on the delivery of quality care. Exploring the detail of individual 
participants’ emotional responses to stress was outside the scope of this 
study and may have been limited by use of participants’ second language 
(Murray and Wynne, 2001), but our findings identify, at minimum, a 
need for supportive supervision (Avortri et al., 2019) for health workers 
exposed to traumatic cases of snakebite management, particularly where 
affected by system under-resourcing. Addressing training and resourcing 
gaps are a priority, but further research on health worker stress and 
emotional responses might identify a need for more specialised psy-
chological support. 
4.4. Study limitations 
Qualitative methods are not generalisable, and our study included 
relatively small numbers of participants, all working in the north of Kitui 
County. Nevertheless, many of our findings concur with snakebite 
research literature, which suggests some findings will be relevant in 
other settings. Our participants also represented only the public health 
system, while private health facilities make up 49 % of health service 
providers in Kenya and differ from public facilities in areas such as cost 
of treatments and facility organisation (Kenya National Coordinating 
Agency for Population and Development et al., 2011). Patient costs were 
perceived to be a significant barrier to care seeking, which would, if 
true, suggest that more snakebite patients attend government facilities 
than private. This is supported by evidence from other poor rural com-
munities in Kenya, where the most commonly used health facilities are 
more likely to be public facilities (Ngugi et al., 2017). Care seeking 
behaviour was raised as an important barrier to effective management of 
snake envenoming, so we recommend triangulating our findings on 
health worker perceptions with research on community perceptions. 
Our study only included one doctor, which is a limitation. However, 
doctors are only commonly found in tier 4 of the Kenyan health system 
(Kenya National Coordinating Agency for Population and Development 
et al., 2011), and our study included tiers 1–4. In addition, clinical of-
ficers in Kenya outnumber doctors and are known to provide doctor-like 
services in rural district hospitals, akin to our study setting (Mbindyo 
et al., 2013). Therefore, the low numbers of doctors in our participants 
also likely reflects the type of staff that commonly deliver snakebite care 
in Kitui County. 
It is possible that health workers felt more inclined to specifically 
raise barriers they felt that K-SRIC could address, such as training. We 
sought to counteract this bias by asking open-ended questions about 
previous experiences of managing snakebite, as well as more specific 
questions on training already received and both enablers and challenges 
in resources and support. Triangulating expressed training needs with 
detail provided on previous training, descriptions of previous 
experiences, and emotions associated with these experiences supports a 
conclusion that identified training needs are real. 
5. Conclusions and recommendations 
Health workers in a range of tier 2, 3 and 4 health facilities in four 
northern sub-counties of Kitui County, Kenya, identified delays and 
health worker knowledge gaps as major challenges in management of 
snake envenoming. Delays were predominantly in care seeking, but also 
in the referral system. This study found that clinical decision-making in 
snakebite management is frequently influenced by knowledge gaps, 
resource shortages, including in medication, equipment, infrastructure 
and staffing, and clinician fears. Past experiences of adverse outcomes of 
snakebite and of antivenom adverse reactions were major influences on 
these fears. The following recommendations arose from our study:  
• Community engagement is required to continue improving care 
seeking behaviour, with research needed on exploring options for 
engaging traditional healers in referring victims to health facilities 
and on options for affordable reliable transport, such as including 
emergency transport costs in health insurance cover  
• Snakebite management training for clinicians is urgently needed, 
which should focus on case and syndromic management, antivenom 
administration and management of adverse-reactions, and deliver 
flow chart management aids where possible  
• Systematic adequate resourcing of health facilities for emergency 
management and observation of patients with snake envenoming is 
required  
• Development of treatments for snake envenoming with lower side 
effect profiles and potential for administration closer to the com-
munity should be a research priority 
• Health workers managing snakebite are exposed to traumatic situa-
tions while feeling under-resourced to respond and should receive 
supportive supervision and resourcing in addition to further research 
on their emotional support needs. 
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